ARDELYX INC
For the period ended Mar 31, 2025. Filed May 1, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed May 1, 2025
ARDX$2.93+1.7%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Statements of Changes in Stockholders’ Equity
(in thousands, except shares)
| Three Months Ended March 31, 2025 | ||||||
|---|---|---|---|---|---|---|
| Common Stock · Additional Paid-In Capital · Accumulated Deficit · Accumulated Other Comprehensive Income · Total Stockholders’ Equity | ||||||
| Shares · Amount | ||||||
| Balance as of December 31, 2024 | 238,015,825 | $24 | $1,058,548 | $(885,340) | $57 | $173,289 |
| Issuance of common stock under employee stock purchase plan | 222,734 | — | 1,015 | — | — | 1,015 |
| Issuance of common stock upon exercise of options | 389,963 | — | 467 | — | — | 467 |
| Issuance of common stock upon vesting of restricted stock units | 572,734 | — | — | — | — | — |
| Stock-based compensation | — | — | 12,088 | — | — | 12,088 |
| Unrealized losses on available-for-sale securities | — | — | — | — | (39) | (39) |
| Net loss | — | — | — | (41,144) | — | (41,144) |
| Balance as of March 31, 2025 | 239,201,256 | $24 | $1,072,118 | $(926,484) | $18 | $145,676 |
| Three Months Ended March 31, 2024 | ||||||
|---|---|---|---|---|---|---|
| Common Stock · Additional Paid-In Capital · Accumulated Deficit · Accumulated Other Comprehensive Income (Loss) · Total Stockholders’ Equity | ||||||
| Shares · Amount | ||||||
| Balance as of December 31, 2023 | 232,453,190 | $23 | $1,012,773 | $(846,204) | $224 | $166,816 |
| Issuance of common stock under employee stock purchase plan | 253,312 | — | 1,038 | — | — | 1,038 |
| Issuance of common stock upon exercise of options | 701,578 | — | 2,183 | — | — | 2,183 |
| Issuance of common stock upon vesting of restricted stock units | 551,664 | — | — | — | — | — |
| Stock-based compensation | — | — | 7,616 | — | — | 7,616 |
| Unrealized losses on available-for-sale securities | — | — | — | — | (244) | (244) |
| Net loss | — | — | — | (26,518) | — | (26,518) |
| Balance as of March 31, 2024 | 233,959,744 | $23 | $1,023,610 | $(872,722) | $(20) | $150,891 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.